Resources - Invokana (canagliflozin) - After first line, take a firm line
Invokana Resources & Supplements Icon

Links to Resources & Supplements

Downey J. The importance of achieving target HbA1c in the early years. Practice Nurse 2018(1):12–16

Achieving good glycaemic control in the early years after diagnosis of type 2 diabetes reduces the time spent in a hyperglycaemic state and thus decreases the ‘glycaemic legacy’ effect – and so can be expected to lessen or delay the occurrence of complications.

View supplement

Bostock-Cox B. Managing type 2 diabetes – beyond glycaemic control. Practice Nurse 2018;48(10):25-29

Recent studies of newer glucose-lowering therapies indicate that some may also help to protect against cardiovascular and other complications of diabetes, beyond simply lowering blood glucose levels.

View supplement

Date of preparation: March 2019 | Job code: UK/INV-18087b